City
Epaper

Those who have contracted COVID-19 infection are eligible for vaccination including precaution dose only after 3 months post recovery

By ANI | Updated: January 22, 2022 13:10 IST

The Centre in a letter to States and Union Territories has said that COVID-19 vaccination, including precaution doses, for individuals having lab test proven coronavirus infection will be deferred by three months after recovery.

Open in App

The Centre in a letter to States and Union Territories has said that COVID-19 vaccination, including precaution doses, for individuals having lab test proven coronavirus infection will be deferred by three months after recovery.

Union Health Ministry Additional Secretary Vikas Sheel in his letter on Friday stated that requests have been received from various quarters for guidance in regard to the administration of precaution dose to the eligible persons having COVID-19 illness.

"Please note that: -In case of individuals having lab test proven SARS-2 COVID-19 illness, all Covid vaccination including Precaution dose to be deferred by 3 months after recovery," it read.

The letter further stated: "I request you to kindly direct the concerned officials to take note."

The suggestion is based on scientific evidence and recommendation of the National Technical Advisory Group on Immunisation, he said.

India has started the vaccination for adolescents aged between 15-18 years from January 3 this year and precaution dose administration from January 10 for healthcare workers, frontline workers and those above 60 years of age with co-morbidities.

The precaution dose administration is based on the completion of nine months after the administration of second dose of the vaccine.

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Union health ministry additionalNational technical advisory group on immunisationVikas sheel
Open in App

Related Stories

NationalIndia should be ready to fight Zika virus in case of an outbreak: NTAGI chief

NationalHPV vaccine to prevent cervical cancer could be manufactured in India by April-May next year: Chief of medical panel

NationalOmicron strains 20-30 pc more infectious: INSACOG to review data of genomic surveillance of COVID variants

NationalCorbevax heterologous COVID-19 booster expected to get final approval from govt soon: Sources

NationalNTAGI recommends vaccination for Typhoid and Cervical cancer: Sources

National Realted Stories

NationalOmar Abdullah meets PM Modi in aftermath of Pahalgam terror attack

NationalPakistan faces critical artillery shortage, can sustain war for just four days

NationalChar Dham Yatra 2025: Uttarakhand Establishes Mobile Network in Rudraprayag, Offers Free WiFi for Pilgrims

NationalWill strongly demand gazette notification at Krishna Tribunal meeting: Siddaramaiah

NationalTejashwi Yadav bats for stronger EBC representation, slams Nitish Kumar govt